Beigene Ltd (NASDAQ:BGNE)
| 380.02 Delayed Data As of Sep 24 |  -5.40 / -1.40%Today’s Change | 219.20 Today|||52-Week Range 426.56 | +47.07% Year-to-Date |
Latest BGNE News | Press Releases
| 2 Outperforming Biotech Stocks to Examine on Covid-19 Vaccine Updates Sep 21 / GuruFocus News - Paid Partner Content | 3 Top Chinese Stocks to Watch in September Sep 15 / MotleyFool.com - Paid Partner Content |
| Why BeiGene's Shares Jumped on Friday Sep 17 / MotleyFool.com - Paid Partner Content | BeiGene's (BGNE) BLA for Tislelizumab in ESCC Accepted by FDA Sep 13 / Zacks.com - Paid Partner Content |
| BeiGene (BGNE) Scores Third FDA Nod for Brukinsa in Lymphoma Sep 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 385.42 |
| Today’s open | 378.87 |
| Day’s range | 372.55 - 381.11 |
| Volume | 8,478 |
| Average volume (3 months) | 297,488 |
| Market cap | $37.5B |
Data as of 4:14pm ET, 09/24/2021
Growth & Valuation
| Earnings growth (last year) | -21.11% |
| Earnings growth (this year) | +37.87% |
| Earnings growth (next 5 years) | +37.00% |
| Revenue growth (last year) | -27.87% |
| P/E ratio | NM |
| Price/Sales | 69.83 |
| Price/Book | 9.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TEVATeva Pharmaceutical | -0.11 | -1.16% |
| BBIOBridgeBio Pharma Inc | -1.35 | -2.71% |
| ---- | ||
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
Data as of 4:15pm ET, 09/24/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | -$4.58 |
| Annual revenue (last year) | $308.9M |
| Annual profit (last year) | -$1.6B |
| Net profit margin | -517.01% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Beijing, Beijing |
Forecasts
